Skip to main content
. 2020 Oct 7;10:16703. doi: 10.1038/s41598-020-73412-6

Table 1.

Characteristics of the study participants (n = 46).

Characteristic Category n Mean (sd) or %
Age All 46 24.2 (8.2)
Sex Males 13 28.3
Females 33 71.7
Body mass index (kg/m2)^ All 46 22.5 (3.8)
 < 25 kg/m2 40 87.0
 ≥ 25 kg/m2 6 13.0
Racial Group Asian 26 56.5
Caucasian 10 21.7
South Asian or Pakistani 4 8.7
Latin, Latino or Latino American 3 6.5
Mixed race 2 4.3
Black 1 2.2
History of cardiovascular problems* Yes 2 4.3
Regular medication use** Yes 10 21.7
Past 24-h alcohol consumption (visit 1) *** Yes 5 11
Past 24-h alcohol consumption (visit 2)^^ Yes 2 5
Past 24-h caffeine consumption (visit 1) Yes 16 35
Past 24-h caffeine consumption (visit 2)^^ Yes 15 37
Time between visits (days) ^^ All who completed both visits 41 14.7 (6.8)

^Body mass index (BMI) cutoff was chosen according to Canadian risk threshold guidelines defining BMI ≥ 25 kg/m2 as overweight or obese68. *High blood pressure (1 participant), history of heart flutters (1 participant). **Birth control (7 participants), Wellbutrin, Cymbalta/Wellbutrin/Abilify (2 participants), Claritin for allergies (1 participant). ***Not reported by 2 participants. ^^5 participants did not do the second visit. There was no reported environmental smoke exposure (if anyone has smoked inside the home or in their vicinity in the past 24 h).